Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)
WORLDWIDE REPORTS

Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)

Tanaka KA
Anesthesiology
January 01,2003
Emory Healthcare
Share this
Abstract

Categories

USA